<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="hep41480-tbl-0005" xml:lang="en" orientation="portrait" position="float">
 <label>Table 5</label>
 <caption>
  <p>Therapeutic Targets for HBV Drugs in Development</p>
 </caption>
 <table frame="hsides" rules="groups">
  <col style="border-right:solid 1px #000000" span="1"/>
  <col style="border-right:solid 1px #000000" span="1"/>
  <thead valign="top">
   <tr style="border-bottom:solid 1px #000000">
    <th align="left" valign="top" rowspan="1" colspan="1">Virus Life Cycle Step</th>
    <th align="center" valign="top" rowspan="1" colspan="1">Therapeutic Drug Class</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="left" rowspan="1" colspan="1">Virus entry into hepatocyte</td>
    <td align="left" rowspan="1" colspan="1">Entry inhibitors</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Virus intracytoplasmic migration to nuclear periphery and nuclear import</td>
    <td align="left" rowspan="1" colspan="1">Tubulin production inhibitor</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Viral uncoating and intranuclear rcDNA release</td>
    <td align="left" rowspan="1" colspan="1">No current drugs</td>
   </tr>
   <tr>
    <td align="left" rowspan="3" colspan="1">cccDNA production, integration, epigenetic modification</td>
    <td align="left" rowspan="1" colspan="1">cccDNA inhibitors (e.g., lymphotoxin beta receptor agonist)</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Epi‚Äêdrugs</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Interferon alpha</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Modification of cccDNA to pgRNA, pgRNA packaging for nuclear export</td>
    <td align="left" rowspan="1" colspan="1">Small interfering RNA</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">pgRNA reverse transcription to progeny rcDNA and capsid packaging</td>
    <td align="left" rowspan="1" colspan="1">Capsid assembly modulators</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1"/>
    <td align="left" rowspan="1" colspan="1">Interferon alpha</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Viral replication through DNA synthesis</td>
    <td align="left" rowspan="1" colspan="1">Nucleoside analogs</td>
   </tr>
   <tr>
    <td align="left" rowspan="2" colspan="1">Capsid incorporation of HBsAg and secretion from hepatocytes</td>
    <td align="left" rowspan="1" colspan="1">Secretion inhibitors</td>
   </tr>
   <tr>
    <td align="left" rowspan="1" colspan="1">Interferon alpha</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot id="hep41480-ntgp-0006">
  <fn id="hep41480-note-0014">
   <p>Abbreviations: ccc, covalently closed circular; DNA, deoxyribonucleic acid; HBsAg, hepatitis B virus surface antigen; pg, pregenomic; rc, relaxed circular; RNA, ribonucleic acid.</p>
  </fn>
 </table-wrap-foot>
 <permissions>
  <copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
 </permissions>
</table-wrap>
